Mebanazine

From Infogalactic: the planetary knowledge core
Jump to: navigation, search
Mebanazine
Mebanazine.svg
Systematic (IUPAC) name
1-phenylethylhydrazine
Clinical data
Legal status
  • ℞ (Prescription only)
Routes of
administration
Oral
Identifiers
CAS Number 65-64-5
ATC code none
PubChem CID: 6179
ChemSpider 5944
UNII Z5R55CJ4CG YesY
ChEMBL CHEMBL1909283
Chemical data
Formula C8H12N2
Molecular mass 136.19 g/mol

Mebanazine (trade name Actomol) is a monoamine oxidase inhibitor (MAOI) of the hydrazine chemical class that was previously used as an antidepressant in the 1960s, but has since been discontinued.[1][2][3]

See also

References

  1. Gilmour SJ (September 1965). "Clinical trial of mebanazine--a new monoamine oxidase inhibitor". The British Journal of Psychiatry : the Journal of Mental Science. 111 (478): 899–902. PMID 5889715.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  2. Barker JC, Jan IA, Enoch MD (November 1965). "A controlled trial of mebanazine ('Actomol') in depression". The British Journal of Psychiatry : the Journal of Mental Science. 111 (480): 1095–100. PMID 5320546.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  3. Knott F (1965). "A preliminary trial of mebanazine in depressive states". The Journal of New Drugs. 5 (6): 345–7. PMID 5327282.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>